| M | T | W | T | F | S | S | |
|---|---|---|---|---|---|---|---|
 | 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
CYTOPIA LIMITED (CYT)
Stock Code: CYT
Listing Date: 1999-03-31 00:00:00
Website: http://www.cytopia.com.au
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Principal Activities:
Biotechnology company focused on the discovery and development of new drugs to treat cancer, specialising in discovering new molecules that can inhibit enzymes known as kinases, an exciting new class of drugs.
Address:
576 Swan Street
RICHMOND
VIC 3121
Phone: (03) 9208 4222
Fax: (03) 9208 4299
Executives & Directors
Mr Robert Watson, Non Exec. Chairman
Mr Andrew Macdonald, CEO
Dr Kevin Healey, Non Exec. Director
Mr Mark Rowsthorn, Non Exec. Director
Dr Geoffrey Vaughan, Non Exec. Director
Mr Rod Lyle, Non Exec. Director
Mr Gavan Flower, CFO
Company Podcasts
Subscribe to current and future audio events for this company by clicking on the podcast icon:
Company ASX Announcements
Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.
Click here to view this company's details on the ASX site
Company Events
| Annual General Meeting | Thu, 20 Nov 2008 11:00AM |
|
| Full Year Results | Fri, 10 Oct 2008 | |
| Interim Results | Fri, 8 Feb 2008 | |
| Annual General Meeting | Thu, 15 Nov 2007 10:00AM |
|
| Full Year Results | Mon, 13 Aug 2007 | |
| Interim Results | Fri, 9 Feb 2007 | |
| Annual General Meeting | Thu, 16 Nov 2006 10:00AM |
|
| Full Year Results | Fri, 11 Aug 2006 | |
| Interim Results | Thu, 9 Feb 2006 | |
| Annual General Meeting | Tue, 22 Nov 2005 10:00AM |
CYTOPIA LIMITED (CYT)
| Chairman and Managing Director Addresses at AGM | Thu, 20 Nov 2008 |
| Results of Meeting | Thu, 20 Nov 2008 |
| Cytopia Doses First Phase Ib/II Brain Cancer Patient | Mon, 17 Nov 2008 |
| Appendix 3B | Thu, 30 Oct 2008 |
| Cytopia Scientific Presentations on JAK2 Inhibitor Program | Thu, 16 Oct 2008 |
| Notice of Annual General Meeting/Proxy Form | Fri, 10 Oct 2008 |
| Annual Report 2008 | Fri, 10 Oct 2008 |
| Cytopia Commences Second Phase II Study in Brain Cancer | Thu, 4 Sep 2008 |
| Newsletter August 2008 Edition | Fri, 29 Aug 2008 |
| Appendix 3B | Mon, 25 Aug 2008 |
| Presentation on JAK2 Inhibitors at American Chemical Society | Tue, 12 Aug 2008 |
| Preliminary Financial Report / Full Year Statutory Accounts | Fri, 8 Aug 2008 |
| Change of Director`s Interest Notice | Mon, 4 Aug 2008 |
| Presentation - Melbourne Broker Briefing | Thu, 31 Jul 2008 |
| Appointment of Study Chairman for JAK2 Clinical Trial | Tue, 29 Jul 2008 |
| Cytopia Strengthens Scientific Team | Thu, 10 Jul 2008 |
| Cytopia to Present Data on FMS Program | Wed, 18 Jun 2008 |
| Release of Abstract for CYT997 Oral Presentation at ASCO | Fri, 16 May 2008 |
| Announces Novel Anti-Cancer Drug Development Collaboration | Thu, 8 May 2008 |
| Change of Director`s Interest Notice | Fri, 2 May 2008 |
| Change of Share Registry Address | Wed, 23 Apr 2008 |
| Newsletter April 2008 Edition | Mon, 21 Apr 2008 |
| Presentation on JAK2 inhibitor at AACR | Wed, 9 Apr 2008 |
| Cytopia Nominates JAK2 Clinical Candidate | Tue, 18 Mar 2008 |
| Anti-Cancer Drug CYT997 Update | Thu, 13 Mar 2008 |
| Half Yearly Report and Accounts | Fri, 8 Feb 2008 |
| Appendix 3B | Fri, 8 Feb 2008 |
| JAK2 Inhibitor Shows Potent Activity in MPD | Wed, 30 Jan 2008 |
| Section 708A Notice | Thu, 20 Dec 2007 |
| Appendix 3B - Share Placement | Thu, 20 Dec 2007 |
| Newsletter December 2007 Issue | Wed, 19 Dec 2007 |
| Placement - Cytopia Raises $5m to Support Clinical Programs | Fri, 14 Dec 2007 |
| Trading Halt | Wed, 12 Dec 2007 |
| Cytopia Commences Phase II Cancer Drug Study | Mon, 3 Dec 2007 |
| Final Directors Interest Notice | Thu, 22 Nov 2007 |
| CYT997 Presentation to AGM | Fri, 16 Nov 2007 |
| Appendix 3B | Fri, 16 Nov 2007 |
| Chairman`s Address to Shareholders | Thu, 15 Nov 2007 |
| Results of Meeting | Thu, 15 Nov 2007 |
| Retirement of Director | Thu, 15 Nov 2007 |
| Cytopia reports final data from Phase I cancer trial | Tue, 13 Nov 2007 |
| Appointment of new CFO and Company Secretary | Mon, 29 Oct 2007 |
| Phase II trial in Multiple Myeloma to begin end 2007 | Wed, 17 Oct 2007 |
| Notice of Annual General Meeting/Proxy Form | Fri, 12 Oct 2007 |
| 2007 Annual Report | Fri, 12 Oct 2007 |
| Change of Company Address | Mon, 1 Oct 2007 |
| Cytopia compounds show potential as treatment for bones loss | Thu, 13 Sep 2007 |
| Newsletter August 2007 Issue | Mon, 3 Sep 2007 |
| Change of Pooled Development Fund status | Fri, 17 Aug 2007 |
| Presentation - Broker Briefing | Wed, 15 Aug 2007 |
Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.